title: Long-term results of endovascular abdominal aortic aneurysm treatment with the first generation of commercially available stent grafts.
abstract: OBJECTIVE
  Little information about the long-term results of endovascular abdominal aortic aneurysm repair is available. This study was performed to evaluate the long-term data of patients treated with the first generation of commercially available stent grafts.
  
  
  METHODS
  Multicenter registry.
  
  
  METHODS
  Sixty-two European centers that participated in the EUROSTAR (EUROpean collaborators on Stent-graft Techniques for abdominal aortic Aneurysm Repair) registry.
  
  
  METHODS
  A total of 1190 patients with a follow-up of up to 8 years, who underwent endovascular abdominal aortic aneurysm repair with a stent graft (Stentor or Vanguard).
  
  
  METHODS
  Elective endovascular abdominal aortic aneurysm repair.
  
  
  METHODS
  The morbidity and mortality data of patients treated with the first-generation stent graft who enrolled in the EUROSTAR registry were analyzed. Incidence rates of complications were calculated to quantify annual risks. Life-table analyses and multivariate Cox proportional hazards models were used for the survival analysis.
  
  
  RESULTS
  Conversion to open repair, aneurysm rupture, all-cause death, and aneurysm-related death occurred in 7.1%, 2.4%, 19.9%, and 3.0% of the patients, respectively. The cumulative percentage of the combined outcome event, conversion-free and rupture-free survival, after 8 years was 48.0%. Procedure-related complications that frequently occurred were endoleak (13.0 cases per 100 patient-years), stenosis/thrombosis (4.6 cases per 100 patient-years), and stent migration (4.3 cases per 100 patient-years).
  
  
  CONCLUSIONS
  Patients treated with the first generation of stent grafts will need lifelong surveillance because of a considerable risk of late complications. How these findings translate to the outcome of newer-generation stent grafts is unknown. For this reason, vigilant surveillance remains indicated in all patients who undergo endovascular abdominal aortic aneurysm repair.
authors.affiliation: EUROSTAR Data Registry Centre, Department of Vascular Surgery, Catharina Hospital, Michelangelolaan 2, 5602 ZA Eindhoven, the Netherlands. EUROstar@iae.nl
authors.forename: Lina J
authors.initials: LJ
authors.lastname: Leurs
authors.forename: Jacob
authors.initials: J
authors.lastname: Buth
authors.forename: Robert J F
authors.initials: RJ
authors.lastname: Laheij
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017544:Aortic Aneurysm, Abdominal / Q000401:mortality / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015607:Stents; D016019:Survival Analysis; D016896:Treatment Outcome